Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism
Wade R. Gutierrez(WinnMed), Rebecca D. Dodd(University of Iowa)
Cited by 9
Related Papers
PRC2 loss drives MPNST metastasis and matrix remodeling
|JCI Insight|2022|21